Flagship Harbor Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $155K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $285K | Sell |
|
|||||
|
2024
Q2 | $339K | Sell |
|
|||||
|
2024
Q1 | $447K | Sell |
|
|||||
|
2023
Q4 | $413K | Buy |
|
|||||
|
2023
Q3 | $273K | Buy |
|
|||||
|
2023
Q2 | $326K | Buy |
|
|||||
|
2023
Q1 | $238K | Buy |
|
|||||
|
2022
Q4 | $206K | Buy |
|
|||||
|
2022
Q3 | $328K | Sell |
|
|||||
|
2022
Q2 | $307K | Sell |
|
|||||
|
2022
Q1 | $322K | Buy |
|
|||||
|
2021
Q4 | $371K | Buy |
|
|||||
|
2021
Q3 | $746K | Hold |
|
|||||
|
2021
Q2 | $746K | Buy |
|
|||||
|
2021
Q1 | $379K | Buy |
|
|||||
|
2020
Q4 | $469K | Buy |
|
|||||
|
2020
Q3 | $251K | Sell |
|
|||||
|
2020
Q2 | $271K | Buy |
|
|||||
|
2020
Q1 | $151K | Buy |
|
|||||
|
2019
Q4 | $162K | Sell |
|
|||||
|
2019
Q3 | $111K | Sell |
|
|||||
|
2019
Q2 | $155K | Hold |
|
|||||
|
2019
Q1 | $118K | Buy |
|
|||||
|
2018
Q4 | $77K | Buy |
|
|||||
|
2018
Q3 | $11K | Sell |
|
|||||
|
2018
Q2 | $21K | Buy |
|